← Back to catalogue
Cobas Ampliprep/ Cobas Taqman Cmv Test
FDA PMAClass II (US FDA PMA)
PMA P110037
Identity
- Trade Name
- COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST) FDA PMA
- Generic Name
- Cytomegalovirus (cmv) dna quantitative assay FDA PMA
Identifiers
- PMA Number
- P110037 FDA PMA
- FDA Product Code
- PAB FDA PMA
Classification
- Device Class
- Class II FDA PMA
- Legislation / Framework
- 21 CFR Part 866.3180 FDA PMA
- Regulation Number
- 866.3180 FDA PMA
- Advisory Committee
- Microbiology FDA PMA
- FDA Decision
- APRL FDA PMA
Cobas Ampliprep/ Cobas Taqman Cmv Test by Roche Molecular Systems, Inc. (cytomegalovirus (cmv) dna quantitative assay) — Class II — FDA_PMA — listed in FDA PMA
Authorization Coverage (1 country)
Regulatory Authorizations
United States Active
FDA_PMA
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA PMA | United States | FDA_PMA | P110037 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Roche Molecular Systems, Inc.
Sources (1)
- FDA PMA P110037 24 fields · synced Jun 18, 2026